Tag: Synergy Pharmaceuticals

  • Volatile Dug Stocks: Depomed Inc. (NASDAQ:DEPO), Pernix Therapeutics Holdings Inc. (NASDAQ:PTX), Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), Amarin Corporation plc (ADR) (NASDAQ:AMRN)

    Dendreon Corporation (NASDAQ:DNDN), reported results for the first quarter ended March 31, 2014. Net product revenue for the quarter was $68.8 million compared to $67.6 million in the first quarter of 2013. Depomed Inc. (NASDAQ:DEPO) net profit margin is 36.10% and weekly performance is -24.18%. On last trading day company shares ended up $10.57. Analysts mean target price for the company is $12.50. Depomed Inc. (NASDAQ:DEPO) distance from 50-day simple moving average (SMA50) is -22.93%.

    On May 7, 2014, Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) received a letter from NASDAQ stating that, as a result of the appointments of Messrs. Sedor and Konidaris to the Board of Directors and Audit Committee, the Company has regained compliance with the requirements of the Listing Rules. Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) shares advanced 10.14% in last trading session and ended the day on $4.78. PTX gross Margin is 48.30% and its return on assets is -10.30%.Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) quarterly performance is 54.69%.

    Synergy Pharmaceuticals announced on 30 April positive top-line results from a phase 2b dose-ranging study assessing plecanatide’s safety and efficacy in 424 patients with irritable bowel syndrome with constipation. The primary objective of this trial was to determine an effective, safe and well tolerated dose for plecanatide phase 3 trials with IBS-C patients. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) shares moved up 0.80% in last trading session and was closed at $3.78, while trading in range of $3.39 – $3.82. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) year to date (YTD) performance is -31.89%.

    Amarin Co. plc (ADR) (NASDAQ:AMRN) was downgraded by stock analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating in a report issued on Friday, TheFlyOnTheWall.com reports. Amarin Corporation plc (ADR) (NASDAQ:AMRN) ended the last trading day at $1.51. Company weekly volatility is calculated as 6.37% and price to cash ratio as 1.36.Amarin Corporation plc (ADR) (NASDAQ:AMRN) showed a negative weekly performance of -11.70%.